Cyxone AB (Sweden) Today
| CYXO Stock | SEK 0.14 0.02 16.67% |
Performance11 of 100
| Odds Of DistressOver 53
|
Cyxone AB is selling for under 0.14 as of the 22nd of May 2024; that is 16.67 percent up since the beginning of the trading day. The stock's last reported lowest price was 0.12. Cyxone AB has 53 percent odds of going through some form of financial distress in the next two years but had a very good returns during the last 90 days. Equity ratings for Cyxone AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of April 2024 and ending today, the 22nd of May 2024. Click here to learn more.
Cyxone AB , a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis and multiple sclerosis and treatments for virally induced acute respiratory disorders. The company was founded in 2015 and is headquartered in Malm, Sweden. The company has 98.44 M outstanding shares. More on Cyxone AB
Moving together with Cyxone Stock
| 0.81 | HNSA | Hansa Biopharma AB | PairCorr |
Moving against Cyxone Stock
| 0.68 | NXTCL | NextCell Pharma AB | PairCorr |
| 0.44 | NANOFS | Nanoform Finland Plc | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cyxone Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cyxone AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cyxone AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Ola Skanung |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Cyxone AB (CYXO) is traded on Stockholm Exchange in Sweden and employs 8 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 52.96 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cyxone AB's market, we take the total number of its shares issued and multiply it by Cyxone AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cyxone AB operates under Healthcare sector and is part of Biotechnology industry. The entity has 98.44 M outstanding shares.
Cyxone AB has accumulated about 56.34 M in cash with (43.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.97, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Cyxone AB Probability Of Bankruptcy
Ownership AllocationCyxone AB holds a total of 98.44 Million outstanding shares. Cyxone AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cyxone Ownership Details
Cyxone AB Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Cyxone AB market risk premium is the additional return an investor will receive from holding Cyxone AB long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cyxone AB. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Cyxone AB's alpha and beta are two of the key measurements used to evaluate Cyxone AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.07 | |||
| Semi Deviation | 2.9 | |||
| Standard Deviation | 4.56 | |||
| Variance | 20.81 |
Cyxone Stock Against Markets
Picking the right benchmark for Cyxone AB stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Cyxone AB stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Cyxone AB is critical whether you are bullish or bearish towards Cyxone AB at a given time. Please also check how Cyxone AB's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cyxone AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
How to buy Cyxone Stock?
Before investing in Cyxone AB, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Cyxone AB. To buy Cyxone AB stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Cyxone AB. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Cyxone AB stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Cyxone AB stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Cyxone AB stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Cyxone AB, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Cyxone AB?
The danger of trading Cyxone AB is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Cyxone AB is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Cyxone AB. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Cyxone AB is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cyxone AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Cyxone Stock analysis
When running Cyxone AB's price analysis, check to measure Cyxone AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyxone AB is operating at the current time. Most of Cyxone AB's value examination focuses on studying past and present price action to predict the probability of Cyxone AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyxone AB's price. Additionally, you may evaluate how the addition of Cyxone AB to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Transaction History View history of all your transactions and understand their impact on performance |